Analyst Ratings for BioMarin Pharmaceutical Inc. (bmrn)

bmrn Rating Summary

bmrn Price Target Summary

* Over Last 12-Mos
  |   Expand Research on bmrn
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $137.06 (-4.7%) * Over Last 12-Mos
Rating Score: 7.7 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/19/2015 Baird
» Updated 6/29/2015
Downgrade Neutral
(Outperform)
133.00
(N/A)
138.66 143.78 3.69% Details
6/5/2015 Barclays New Coverage Overweight
(N/A)
150.00
(N/A)
120.46 143.78 19.36% Details
Like BMRN Ratings? Also take a look at SNY, SAN, RNA, SRPT

BMRN Ratings News